{"DataElement":{"publicId":"6788016","version":"1","preferredName":"Human Papillomavirus Transforming Protein E6 E7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Status Result","preferredDefinition":"The text response that indicates the Human Papillomavirus E6/E7 mRNA status detected by reverse transcriptase-polymerase chain reaction method.","longName":"HPVE6E7_PCR_PRF_RES","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6776686","version":"1","preferredName":"Papillomavirus Transforming Protein E6 Protein E7, Human Papillomavirus Type 16 Human Papillomavirus mRNA Reverse Transcriptase-Polymerase Chain Reaction Status","preferredDefinition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation._Protein E7 (98 aa, ~11 kDa) is encoded by the human papillomavirus type 16 E7 gene. This protein is involved in the modulation of the activity of both retinoblastoma protein and histone deacetylases in the infected host cell, which is associated with viral genome replication and host cell transformation._Any RNA molecule that is the product of transcription of a human papillomavirus gene and contains coding information that can be translated into the amino acid sequence of a protein._A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase._A condition or state at a particular time.","longName":"6776671v1.0:6776684v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6776671","version":"1","preferredName":"Papillomavirus Transforming Protein E6 Protein E7, Human Papillomavirus Type 16 Human Papillomavirus mRNA","preferredDefinition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.:Protein E7 (98 aa, ~11 kDa) is encoded by the human papillomavirus type 16 E7 gene. This protein is involved in the modulation of the activity of both retinoblastoma protein and histone deacetylases in the infected host cell, which is associated with viral genome replication and host cell transformation.:Any RNA molecule that is the product of transcription of a human papillomavirus gene and contains coding information that can be translated into the amino acid sequence of a protein.","longName":"C19170:C1179:C156861","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillomavirus Transforming Protein E6","conceptCode":"C19170","definition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Protein E7, Human Papillomavirus Type 16","conceptCode":"C1179","definition":"Protein E7 (98 aa, ~11 kDa) is encoded by the human papillomavirus type 16 E7 gene. This protein is involved in the modulation of the activity of both retinoblastoma protein and histone deacetylases in the infected host cell, which is associated with viral genome replication and host cell transformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Human Papillomavirus mRNA","conceptCode":"C156861","definition":"Any RNA molecule that is the product of transcription of a human papillomavirus gene and contains coding information that can be translated into the amino acid sequence of a protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC495E8-6305-17C6-E053-F662850A30A7","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6776684","version":"1","preferredName":"Reverse Transcriptase-Polymerase Chain Reaction Status","preferredDefinition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.:A condition or state at a particular time.","longName":"C18136:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC4BDC5-3FC7-52C8-E053-F662850A0B5A","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC4BDC5-3FD8-52C8-E053-F662850A0B5A","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeDescription":"Curated to support Head and Neck Cancers","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6788014","version":"1","preferredName":"Reverse Transcriptase Polymerase Chain Reaction Result","preferredDefinition":"The result of an action.","longName":"6788014v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BB783D0-780B-0352-E053-F662850AA414","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"ONEDATA","dateModified":"2019-06-19","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2840098","version":"1","preferredName":"Negative Finding","longName":"2840098","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635F3981-C786-F359-E040-BB89AD435EC5","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BB783D0-7815-0352-E053-F662850AA414","beginDate":"2018-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"ONEDATA","dateModified":"2019-06-19","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"5042698","version":"1","preferredName":"Positive Finding","longName":"5042698","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BCDB4E-8EE7-8E8D-E050-BB89AD432DF3","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-11-04","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BB783D0-781F-0352-E053-F662850AA414","beginDate":"2018-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"ONEDATA","dateModified":"2019-06-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB783D0-77F3-0352-E053-F662850AA414","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeDescription":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000454","version":"1","longName":"Head and Neck","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"HPV-E6/E7 mRNA status by RT-P","type":"Preferred Question Text","description":"HPV-E6/E7 mRNA status by RT-PCR","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1CB4A-2C90-27A5-E053-F662850AE5E6","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeDescription":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}